Market Tracker

03/28 5:16pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

20.65
Delayed Data
As of Mar 28
 +0.26 / +1.28%
Today’s Change
9.23
Today|||52-Week Range
22.92
+100.88%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close20.39
Today’s open20.38
Day’s range19.99 - 20.88
Volume265,996
Average volume (3 months)296,753
Market cap$595.7M
Dividend yield--
Data as of 3:59pm ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)-108.51%
Earnings growth (this year)+4.76%
Earnings growth (next 5 years)--
Revenue growth (last year)-47.78%
P/E ratioNM
Price/Sales8.33
Price/Book4.59

Competitors

 Today’s
change
Today’s
% change
ENTAEnanta Pharmaceutica...-0.13-0.41%
CRHMCRH Medical Corp-0.05-0.60%
RVNCRevance Therapeutics...-0.15-0.74%
RETAReata Pharmaceutical...-2.43-9.54%
Data as of 4:01pm ET, 03/28/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.82
Annual revenue (last year)$35.8M
Annual profit (last year)-$85.2M
Net profit margin-238.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts